Aurigene Discovery Technologies Limited

Quick facts

Phase 2 pipeline

• AUR101 · Oncology
  AUR101 is a small molecule inhibitor of the Bruton's tyrosine kinase (BTK) enzyme.

Phase 1 pipeline

• AUR103 Calcium
• AUR104
• AUR105
• AUR106
• AUR107
• AUR108
• AUR112

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aurigene Discovery Technologies Limited portfolio CI brief
• Aurigene Discovery Technologies Limited pipeline updates RSS